Retinoblastoma Patient Clinical Database and Tissue Repository

Plain-language summary

This study aims to build a clinical database and tissue repository by collecting clinical data and tissue samples from patients with retinoblastoma. All patients from 0 days to 18 years of age with unilateral or bilateral retinoblastoma seen at Children's Hospital Los Angeles could take part. It is a study without a phase designation and is still recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

Children's Hospital Los Angeles

Start date

1/1/2017

Estimated completion

12/31/2030

Countries

United States, Canada

Related genes

Locations

• Phoenix, United States
• Los Angeles, United States
• Atlanta, United States
• Chicago, United States
• Portland, United States
• Philadelphia, United States
• Memphis, United States
• Seattle, United States
• Toronto, Canada

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* All patients, age 0 days to 18 years, with a diagnosis unilateral or bilateral retinoblastoma (RB) seen at CHLA (Children's Hospital Los Angeles).

Exclusion Criteria:

* Patients referred for second opinions only and not treated at CHLA for any reason.